These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24151161)

  • 1. Twice-weighted multiple interval estimation of a marginal structural model to analyze cost-effectiveness.
    Goldfeld KS
    Stat Med; 2014 Mar; 33(7):1222-41. PubMed ID: 24151161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.
    Stamey JD; Beavers DP; Faries D; Price KL; Seaman JW
    Pharm Stat; 2014; 13(1):94-100. PubMed ID: 24446072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tube-feeding versus hand-feeding nursing home residents with advanced dementia: a cost comparison.
    Mitchell SL; Buchanan JL; Littlehale S; Hamel MB
    J Am Med Dir Assoc; 2004; 5(2 Suppl):S22-9. PubMed ID: 14984607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis and policy choices: investing in health systems.
    Murray CJ; Kreuser J; Whang W
    Bull World Health Organ; 1994; 72(4):663-74. PubMed ID: 7923545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting.
    Zhang Y; Kivipelto M; Solomon A; Wimo A
    J Alzheimers Dis; 2011; 26(4):735-44. PubMed ID: 21709377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.
    Singh S; Sun H; Anis AH
    J Rheumatol; 2004 Aug; 31(8):1607-13. PubMed ID: 15290742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tube-feeding versus hand-feeding nursing home residents with advanced dementia: a cost comparison.
    Mitchell SL; Buchanan JL; Littlehale S; Hamel MB
    J Am Med Dir Assoc; 2003; 4(1):27-33. PubMed ID: 12807594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prospective reimbursement on nursing home costs.
    Coburn AF; Fortinsky R; McGuire C; McDonald TP
    Health Serv Res; 1993 Apr; 28(1):45-68. PubMed ID: 8463109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic aspects of dementia special care units in Veterans Affairs nursing homes.
    Bass E; Putney K; Alvear M
    J Am Med Dir Assoc; 2005; 6(4):276-80. PubMed ID: 16005415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Model of costs of care for dementia: community-dwelling vs. institutionalization].
    van der Roer N; Goes ES; Blom M; Busschbach JJ
    Tijdschr Gerontol Geriatr; 2000 Apr; 31(2):55-61. PubMed ID: 10816892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
    Willan AR; O'Brien BJ
    Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Palliative care in dementia and the dismantling of the treatment function of nursing homes].
    Weeder W
    Tijdschr Gerontol Geriatr; 2007 May; 38(2):102. PubMed ID: 17605287
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of multidisciplinary wound care in nursing homes: a pseudo-randomized pragmatic cluster trial.
    Vu T; Harris A; Duncan G; Sussman G
    Fam Pract; 2007 Sep; 24(4):372-9. PubMed ID: 17602174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Net economic costs of dementia in Canada.
    Ostbye T; Crosse E
    CMAJ; 1994 Nov; 151(10):1457-64. PubMed ID: 7954140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the censored cost-effectiveness analysis using copula information.
    Fontaine C; Daurès JP; Landais P
    BMC Med Res Methodol; 2017 Feb; 17(1):27. PubMed ID: 28202010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
    Nelson CL; Sun JL; Tsiatis AA; Mark DB
    Stat Med; 2008 Nov; 27(26):5525-55. PubMed ID: 18613251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of dementia: impact of disease progression estimated in longitudinal data.
    Andersen CK; Lauridsen J; Andersen K; Kragh-Sørensen P
    Scand J Public Health; 2003; 31(2):119-25. PubMed ID: 12745762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.